UBS analyst Luiz Carvalho downgrades Ecopetrol (NYSE:EC) from Buy to Neutral.
What’s Going On With Capricor Therapeutics Stock Tuesday?
Capricor Therapeutics announced successful completion of a Type-B meeting with the U.S. Food and Drug Administration (FDA).